Results 101 to 110 of about 16,138 (287)
ABSTRACT Objective Minor strokes may be associated with early neurological deterioration (END) and disabilities. The objective was to investigate the role of serum glial fibrillary acidic protein (GFAP) levels in predicting END. Methods Data originated from a multicenter cohort study conducted prospectively.
Jie Zhou +45 more
wiley +1 more source
Myalgic encephalomyelitis/chronic fatigue syndrome: current state of the problem (review article)
This review article elucidates contemporary concepts regarding the molecular and cellular mechanisms underlying structural and functional alterations in the brain associated with myalgic encephalomyelitis/chronic fatigue syndrome, which is currently ...
L.A. Dzyak +3 more
doaj +1 more source
Stage‐Specific Patterns of Imaging and Non‐Motor Biomarkers in Spinocerebellar Ataxia Type 3
ABSTRACT Objective Advancements in disease‐modifying therapies for spinocerebellar ataxia Type 3 (SCA3) underscore the need for robust biomarkers to monitor disease progression and evaluate treatment efficacy. Although motor phenotypes have been well characterized, less is known about non‐motor and imaging‐based features across different disease stages.
Chun Li +17 more
wiley +1 more source
Role of Astrocytes in Central Respiratory Control
Astrocytes, once regarded primarily as structural and metabolic support cells, are now increasingly recognized as active participants in neural information processing.
Yasumasa Okada +6 more
doaj +1 more source
Cholesterol is an essential component for neural physiology. Cholesterol metabolism in brain is independent from that in peripheral tissues due to blood⁃brain barrier (BBB).
ZHUO Jie
doaj
A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone
ABSTRACT Objective Plasma p‐Tau217 leaves 30%–50% of patients in an indeterminate “gray zone” often requiring Aβ‐PET. We developed GRAD (Gatekeeper‐Reflex for Alzheimer's Disease), a two‐stage Aβ‐positivity prediction model to improve classification while reserving Aβ‐PET for residual uncertainty.
Harthik Parankusham +7 more
wiley +1 more source
Apolipoprotein E and Alzheimer’s Disease: Risk, Mechanisms, and Treatment
Alzheimer’s disease (AD) is the most common form of dementia, and its prevalence is rapidly increasing with the aging population. Among the growing number of genetic risk factors, apolipoprotein E (ApoE) is the most prevalent and strongest risk factor ...
CHEN Shi-Yu +10 more
doaj +1 more source
NEUROGLIA. Morfología de la célula de Deiters. ─ Tipo neuróglico de la substancia blanca. ─ Tipo neuróglico de la gris. ─ Célula epitelial. ─ Estructura de la neuroglia.
Freire, Miguel
core
ABSTRACT Background Blood‐based biomarkers are increasingly used to identify Alzheimer's disease (AD) pathology and may play an important role in early disease screening and participant selection for clinical trials. However, their performance across stages of cognitive impairment remains unclear. This study examined whether plasma biomarkers differ in
Maryam Abdolmaleki +7 more
wiley +1 more source
Schematic illustration of LNP‐MPG nuclei‐targeting delivery of HMW‐FGF2 promoting histone acetylation to regulate the fate of DPSCs and treat spinal cord injury. LNPs components include pHMW‐FGF2 plasmid, DSPC, Dlin‐MC3‐DMA, cholesterol, and PEG2000, and are modified with MPG to form HMW‐FGF2@LNP‐MPG (HLM). HLM nuclei‐targets DPSCs to deliver HMW‐FGF2,
Heng Zhou +6 more
wiley +1 more source

